Transplantation Market Size & Trends
The global transplantation market size was estimated at USD 15.0 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030. Growing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure is a major factor contributing to the market growth. Organ failure usually occurs due to various factors such as serious trauma, loss of blood, poisoning, drug abuse, leukemia, sepsis, and other acute diseases. Demand for tissue and organ transplantation, mainly kidney, heart, liver, and lungs, is very high globally. Unhealthy dietary habits, alcohol consumption, lack of exercise, and drug abuse are some leading causes of organ failure. Thus, demand for transplantation products is expected to rise soon.
After a transplantation surgery, the recipients are prescribed powerful immunosuppressive drugs; thus, increasing their susceptibility to infectious diseases as their immunity is weakened. This can be attributed to the decline in transplantation numbers in many countries amid the COVID-19 situation. Moreover, the shortage of resources such as primary protective equipment, ICU, and blood products during the pandemic has contributed to the sharp fall in the market’s revenue in 2020.
Gather more insights about the market drivers, restrains and growth of the Global Transplantation Market
Product Insights
Tissue products were the highest revenue-generating segment in 2022 with a market share of 57.7%. Major products used for tissue or organ transplantation are tissue products, immunosuppressants, and preservation solutions. The increasing number of transplantation procedures such as that of cochlear, heart valves, bone marrow, and orthopedic soft tissues is attributed to the growth of the segment. In addition, new product development is also fueling market growth.
Application Insights
Tissue transplantation dominates the market with market size of 79.2 billion in 2022. This is since the replacement of skin, cornea, bones, heart valves, tendons, nerves, and veins are most commonly performed procedure worldwide. The escalating number of burn and accident cases is expected to propel the demand for tissue products. According to the European Road Safety Observatory report, there were 102,362 injury accidents were reported in Spain. Thus, creating the demand for tissue transplantation.
End-use Insights
The hospitals segment held the largest market share of 49.5% in the year 2022. Many organ and tissue transplant procedures are conducted at hospitals as they are primary treatment centers. Additionally, the emergence of hospitals with developed infrastructure is further expected to fuel market growth. The majority of these hospitals have access to well-defined databases to check for the availability of organs aiding in rapid medical intervention.
Regional Insights
In 2022, North America dominated the transplantation market with a market share of 39.0% and is expected to maintain its dominance throughout the study period. Well-developed healthcare facilities and the local presence of many large biotechnology and medical devices companies, such as Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; and Stryker are supporting the market growth.
Browse through Grand View Research's Medical Devices Industry Research Reports.
- Electrophysiology Devices Market Size, Share & Trends Analysis Report By Device Type (Ablation Catheters, Diagnostic Catheters, Laboratory Devices, Access Devices), By Indication, By End-use, By Region, And Segment Forecasts, 2024 - 2030
- Vital Signs Monitoring Devices Market Size, Share & Trends Analysis Report By Product (BP Monitors, Pulse Oximeters), By End-use (Hospitals, Ambulatory Centers), By Region, And Segment Forecasts, 2023 - 2030
Key Companies & Market Share Insights
The market is highly fragmented with the presence of many large, small, and medium-scale vendors. The leading players in the industry are Zimmer Biomet; Medtronic; Stryker Corporation. These players are involved in launching new products, mergers & acquisitions, and regional expansion to gain maximum revenue share in the industry. Mergers and acquisitions support vendors in expanding their existing product portfolio and geographical reach. For instance, In April 2023, a team of surgeons in Spain performed world’s first robotic lung transplant, a novel lung transplant method that uses robot labelled as Da Vinci.
Rising regulatory approvals for allografts, autologous grafts, and other materials along with the development of innovative products, such as 3D bioprinting, have led to high demand for transplant products. This 3D bioprinting can be used to regenerate tissues and organs. For instance, in September 2020 Israel-based CollPlant Biotechnologies and United therapeutics announced a collaboration to include 3D bioprinting in the development of human kidneys for transplant.
Some of the prominent players in the global transplantation market include:
- Abbvie, Inc
- Arthrex, Inc.
- Zimmer Biomet
- Medtronic
- Novartis AG
- Strykers
- 21st Century Medicine
- BiolifeSolutions, Inc
- Teva Pharmaceuticals
- Veloxis Pharmaceutical
Transplantation Market Segmentation
Grand View Research has segmented the global transplantation market on product, application, end-use, and region:
Transplantation Product Outlook (Revenue, USD Million; 2018 - 2030)
- Tissue Products
- Immunosuppressive Drugs
- Preservation Solution
Transplantation Application Outlook (Revenue, USD Million; 2018 - 2030)
- Organ Transplantation
- Tissue Transplantation
Transplantation End Use Outlook (Revenue, USD Million; 2018 - 2030)
- Hospitals
- Transplant Centers
- Others
Transplantation Regional Outlook (Revenue, USD Million; 2018 - 2030)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- Kuwait
Order a free sample PDF of the Transplantation Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Explore Horizon, the world's most expansive market research database